Alpine Global Management’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Alpine Global Management’s Portfolio GRNAW Stock Details GRNAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-132,426	Closed	-$102	–	682
2022 Q1	$102	Hold	132,426	–	–	0.02%	281
2021 Q4	$159K	Buy	132,426 +32,426	+32%	+$37K	0.02%	499
2021 Q3	$101K	Buy	+100,000	New	+$105K	0.02%	254

Other funds holding GRNAW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Alpine Global Management's GRNAW Position: Q2 2022 in Review

Alpine Global Management sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q2 2022, closing a stake of 132,426 shares — an estimated $102 sold.

Alpine Global Management first reported a position in GRNAW in Q3 2021 and held it in 3 quarters. The position peaked at $159K in Q4 2021. 21 funds tracked by Wall St. Rank hold GRNAW as of Q2 2022.

Alpine Global Management reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q2 2022 after selling out during the quarter.
Alpine Global Management sold 132,426 GreenLight Biosciences Holdings, PBC Warrant shares in Q2 2022, an estimated $102.
Alpine Global Management first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q3 2021 and held it in 3 quarters.
Alpine Global Management's GreenLight Biosciences Holdings, PBC Warrant position peaked at $159K in Q4 2021.
21 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q2 2022.

Based on Alpine Global Management's 13F filing for Q2 2022, filed 15 Aug 2022.